Many patients with T2D also have underlying comorbidities that may affect the pharmacokinetic profile of treatment, and of particular importance is the impact of renal or hepatic impairment
Some studies have observed a potential link between these medications and a reduced risk of mental illness worsening, which is a significant development
Diarrhea has also been observed, particularly with higher or repeated doses
Brain fog often stems from inflammation, poor gut health, mitochondrial dysfunction, and metabolic issues
Patients should be educated about symptoms of hyperglycaemia (increased thirst, frequent urination, fatigue) and hypoglycaemia if taking other diabetes medications
Its typically safe to take these medications together with Farxiga